
Rita J Desai
Examiner (ID: 6660, Phone: (571)272-0684 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1625 |
| Total Applications | 2152 |
| Issued Applications | 1294 |
| Pending Applications | 146 |
| Abandoned Applications | 716 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13314111
[patent_doc_number] => 20180208592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => BENZOQUINOLONE INHIBITORS OF VMAT2
[patent_app_type] => utility
[patent_app_number] => 15/718666
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15718666
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/718666 | BENZOQUINOLONE INHIBITORS OF VMAT2 | Sep 27, 2017 | Abandoned |
Array
(
[id] => 14438903
[patent_doc_number] => 20190177324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => BETA-LACTAMASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/323668
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323668
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323668 | Beta-lactamase inhibitors | Sep 27, 2017 | Issued |
Array
(
[id] => 16634283
[patent_doc_number] => 10912769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => 1-[(pyridin-3-yl-sulfonyl)-1H-pyrrol-3-yl] methanamine derivative and pharmaceutical composition and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/337714
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6284
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337714 | 1-[(pyridin-3-yl-sulfonyl)-1H-pyrrol-3-yl] methanamine derivative and pharmaceutical composition and use thereof | Sep 26, 2017 | Issued |
Array
(
[id] => 14516331
[patent_doc_number] => 10335399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2--negative allosteric modulators, compositions, and their use
[patent_app_type] => utility
[patent_app_number] => 15/713769
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29062
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15713769
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/713769 | Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2--negative allosteric modulators, compositions, and their use | Sep 24, 2017 | Issued |
Array
(
[id] => 12624444
[patent_doc_number] => 20180099978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO
[patent_app_type] => utility
[patent_app_number] => 15/712850
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15712850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/712850 | Processes of preparing a JAK1 inhibitor and new forms thereto | Sep 21, 2017 | Issued |
Array
(
[id] => 16290058
[patent_doc_number] => 10766894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Aza-indazole compounds for use in tendon and/or ligament injuries
[patent_app_type] => utility
[patent_app_number] => 16/335496
[patent_app_country] => US
[patent_app_date] => 2017-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 30917
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335496
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335496 | Aza-indazole compounds for use in tendon and/or ligament injuries | Sep 20, 2017 | Issued |
Array
(
[id] => 13207029
[patent_doc_number] => 10117865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => CCR6 compounds
[patent_app_type] => utility
[patent_app_number] => 15/709012
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15024
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709012
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709012 | CCR6 compounds | Sep 18, 2017 | Issued |
Array
(
[id] => 17323559
[patent_doc_number] => 11214553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Method for preparing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
[patent_app_type] => utility
[patent_app_number] => 16/473242
[patent_app_country] => US
[patent_app_date] => 2017-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 10697
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/473242 | Method for preparing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid | Sep 17, 2017 | Issued |
Array
(
[id] => 14808199
[patent_doc_number] => 20190270709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => OPTIMIZED PRODUCTION METHOD FOR PEST CONTROL AGENT
[patent_app_type] => utility
[patent_app_number] => 16/333712
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333712
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333712 | OPTIMIZED PRODUCTION METHOD FOR PEST CONTROL AGENT | Sep 14, 2017 | Abandoned |
Array
(
[id] => 14581211
[patent_doc_number] => 20190218214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => Inhibition of BMP Signaling Compounds, Compositions and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/333201
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333201
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333201 | Inhibition of BMP Signaling Compounds, Compositions and Uses Thereof | Sep 13, 2017 | Abandoned |
Array
(
[id] => 12239857
[patent_doc_number] => 20180072721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5-DISUBSTITUTED-3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES'
[patent_app_type] => utility
[patent_app_number] => 15/705005
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67374
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705005
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705005 | 3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases | Sep 13, 2017 | Issued |
Array
(
[id] => 16816758
[patent_doc_number] => 11001564
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
[patent_app_type] => utility
[patent_app_number] => 16/330328
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46284
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330328 | Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same | Sep 12, 2017 | Issued |
Array
(
[id] => 12706624
[patent_doc_number] => 20180127374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => BENZOMORPHAN COMPOUNDS AS OPIOID RECEPTORS MODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/703453
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703453
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703453 | BENZOMORPHAN COMPOUNDS AS OPIOID RECEPTORS MODULATORS | Sep 12, 2017 | Abandoned |
Array
(
[id] => 14566745
[patent_doc_number] => 20190210979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => METHOD FOR PRODUCING THE CRYSTALLINE FORM OF MODIFICATION A OF CALCOBUTROL
[patent_app_type] => utility
[patent_app_number] => 16/336217
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336217
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/336217 | Method for producing the crystalline form of modification a of calcobutrol | Sep 10, 2017 | Issued |
Array
(
[id] => 16743241
[patent_doc_number] => 10968215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Pyrido five-element aromatic ring compound, preparation method therefor and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/331090
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40254
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331090
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331090 | Pyrido five-element aromatic ring compound, preparation method therefor and use thereof | Sep 5, 2017 | Issued |
Array
(
[id] => 16704313
[patent_doc_number] => 10954233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Compounds and compositions as inhibitors of endosomal toll-like receptors
[patent_app_type] => utility
[patent_app_number] => 16/330820
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40500
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330820
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330820 | Compounds and compositions as inhibitors of endosomal toll-like receptors | Sep 5, 2017 | Issued |
Array
(
[id] => 15944919
[patent_doc_number] => 10660333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Substituted 2-heterocyclylimidazolylcarboxamides as pesticides
[patent_app_type] => utility
[patent_app_number] => 16/323889
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36685
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1027
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323889 | Substituted 2-heterocyclylimidazolylcarboxamides as pesticides | Aug 3, 2017 | Issued |
Array
(
[id] => 13196063
[patent_doc_number] => 10112941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Tricyclic compounds as anticancer agents
[patent_app_type] => utility
[patent_app_number] => 15/661373
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 129532
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661373
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/661373 | Tricyclic compounds as anticancer agents | Jul 26, 2017 | Issued |
Array
(
[id] => 14406673
[patent_doc_number] => 20190169180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => PIPERDINE CXCR7 RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/320906
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320906 | Piperdine CXCR7 receptor modulators | Jul 26, 2017 | Issued |
Array
(
[id] => 12023603
[patent_doc_number] => 20170313703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'Cis-tetrahydro-spiro(cyclohexane-1,1?-pyrido[3,4-b]indole)-4-amine Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/654389
[patent_app_country] => US
[patent_app_date] => 2017-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28257
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15654389
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/654389 | Cis-tetrahydro-spiro(cyclohexane-1,1?-pyrido[3,4-b]indole)-4-amine Compounds | Jul 18, 2017 | Abandoned |